1月20日, 南向资金增持昭衍新药9.11万股,连续5日增持。截止当日收盘,港股通共持有昭衍新药4545.25万股,占流通股38.19%。港股通增持金额前五个股分别为腾讯控股、中芯国际、小米集团-W、美团-W、工商银行。昭衍新药近5个交易日上涨3.62%,港股通累计增持57.50万股;近20个交易日下跌8.90%,港股通累计增持121.69万股。|1月20日港股通(深)十大成交榜|||#|股票简称...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.